LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Glenmark Pharma trades higher on the bourses

Glenmark Pharma trades higher on the bourses (16-Jan-2018)

Glenmark Pharmaceuticals is currently trading at Rs. 624.05, up by 1.00 points or 0.16% from its previous closing of Rs. 623.05 on the BSE.

The scrip opened at Rs. 625.20 and has touched a high and low of Rs. 630.95 and Rs. 624.00 respectively. So far 22854 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 973.10 on 07-Feb-2017 and a 52 week low of Rs. 528.00 on 18-Dec-2017.

Last one week high and low of the scrip stood at Rs. 642.00 and Rs. 600.30 respectively. The current market cap of the company is Rs. 17624.02 crore.

The promoters holding in the company stood at 46.53%, while institutions and non-institutions held 38.56% and 14.92% respectively.

Glenmark Pharmaceuticals has been granted permission by the Directorate General of Health Services, Central Drugs Standard Control Organization (CDSCO), Government of India, to conduct a Phase IIb dose range finding study to evaluate safety and efficacy of GRC 27864 in patients with moderate osteoarthritic pain.

GRC 27864 is a potent, selective, and orally bioavailable inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1), a novel therapeutic target in pain management, which is up-regulated under inflammatory conditions.

The Phase II study is planned in India in 624 patients of osteoarthritis of the knee and hip to evaluate safety, efficacy and; biomarkers to characterize novel mechanism differentiated from existing NSAID's and selective COX-2 inhibitors. Primary objective of the study is to evaluate safety and tolerability of GRC 27864 given orally at daily doses of 10 mg, 25 mg and 75 mg for 12 weeks compared to placebo, in patients with moderate osteoarthritic pain.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).


Top News Today
MTNL investing Rs 190 crore to upgrade services
(21-May-2018)

MTNL investing Rs 190 crore to upgrade servicesMahanagar Telephone Nigam (MTNL) is investing Rs 190 crore to upgrade its services and may also get 4G spectrum, which will support the company to stay relevant in the highly competitive market.MTNL was......click on news to read complete article.

RIL gets environmental clearance for expansion project in Maharashtra
(21-May-2018)

RIL gets environmental clearance for expansion project in MaharashtraReliance Industries (RIL) has received environment clearance for the expansion and optimisation of its petrochemical complex at Nagothane in Raigad district of Maharashtra at an estimated cost of Rs 2,338......click on news to read complete article.

L&T's arm bags two orders from HURL
(21-May-2018)

L&TLarsen & Toubro's (L&T's) wholly owned subsidiary -- L&T Hydrocarbon Engineering (LTHE) in consortium with TechnipFMC has won two significant orders from Hindustan Urvarak and Rasayan......click on news to read complete article.

International Stock News
Asian markets trade firm as US-China trade tensions ease
(21-May-2018)

Asian markets trade firm as US-China trade tensions easeAsian markets are trading mostly in green in early deals on Monday, after fears of a trade war between the U.S. and China receded following weekend developments. U.S. Treasury Secretary Steve Mnuchin said......click on news to read complete article.

US markets closed mostly lower; Dow ekes minor gain
(19-May-2018)

US markets closed mostly lower; Dow ekes minor gainThe US markets closed lower on Friday, with major indexes posting modest weekly declines as investors grappled with lingering uncertainty over trade negotiations between the US and China, as well as bond......click on news to read complete article.

US markets closed mostly lower; Dow ekes minor gain
(19-May-2018)

US markets closed mostly lower; Dow ekes minor gainThe US markets closed lower on Friday, with major indexes posting modest weekly declines as investors grappled with lingering uncertainty over trade negotiations between the US and China, as well as bond......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.